TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Bioventus Stock

Bioventus Stock

bioventusglobal.comHealthcare / Other HealthcareFounded: 2012Funding to Date: $41MM

Bioventus is a biotechnology company developing solutions for musculoskeletal healing and regeneration that engage and enhance the body’s healing process.

Buy or sell Bioventus stockLearn more about Bioventus IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Bioventus, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Bioventus’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Bioventus.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Leigh Stradford
Senior Vice President & Chief Human Resources Officer
Anthony Bihl III
Chief Executive Officer & Board Member
Alessandra Pavesio
Chief Science Officer & Senior Vice President
John Nosenzo
Chief Commercial Officer
Greg Anglum
Senior Vice President & Chief Financial Officer

Board Members

Anthony Bihl III
David Parker
Ampersand Capital Partners
Evan Melrose MD
Spindletop Capital
Cyrille Petit
Smith & Nephew
Guido Neels
EW Healthcare Partners
Martin Sutter
EW Healthcare Partners
Michael Minogue
Matthew Stober
Smith & Nephew
Guy Nohra
Alta Partners
Phil Cowdy
William Hawkins III
EW Healthcare Partners

Frequently Asked Questions About Bioventus’ Stock

plusminus
Can you buy Bioventus’ stock?
Bioventus is not publicly traded on NYSE or NASDAQ in the U.S. To buy Bioventus’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Bioventus’ stock?
Yes, you can sell stock of a private company like Bioventus. Forge can help you sell your Bioventus stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Bioventus’ stock price?
Bioventus is a privately held company and therefore does not have a public stock price. However, you may access Bioventus’ private market stock price with Forge Data.
plusminus
What is Bioventus’ stock ticker symbol?
Bioventus does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Bioventus in the Other Healthcare sector

Phil

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$300.91MM

Insightec

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$500MM

Blink Health

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$1.26B

Selkirk Pharma

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.45B

Parallel

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.47B

Zephyr AI

Sector
Healthcare / Other Healthcare
 
 

Reven Pharmaceuticals

Sector
Healthcare / Other Healthcare
 
 

Nutrafol

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$150MM

Lumicell

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$315.94MM

News Highlights

Mass Device 07/01/2016
Bioventus files for $150m IPO
Orthobiologics maker Bioventus yesterday registered for an initial public offering it plans to use to pay off debt. Durham, N.C.-based Bioventus was formed in 2012 when Smith & Nephew (NYSE:SNN) spun out its biologics and clinical therapies division in a joint venture with venture capital firm Essex Woodlands. In October 2014 Bioventus acquired the OsteoAMP product line from Advanced […]

Trending Companies

Frequently Asked Questions

Updated on: Apr 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.